Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2,127 |
|
|||||
| News | - | ||||||
| Day High | 2.37 | Low High |
|||||
| Day Low | 2.325 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| DiaMedica Therapeutics Inc | DMAC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.065 | -2.72% | 2.325 | 09:41:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.37 | 2.325 | 2.37 | 2.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5 | 2,127 | $ 2.36 | $ 5,016 | - | 1.9382 - 4.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:41:03 | 25 | $ 2.30 | USD |
DiaMedica Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 90.71M | 37.95M | - | 0 | -19.38M | -0.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
DiaMedica Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DMAC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.58 | 2.68 | 2.25 | 2.42 | 30,810 | -0.255 | -9.88% |
| 1 Month | 3.05 | 3.1373 | 2.25 | 2.64 | 21,028 | -0.725 | -23.77% |
| 3 Months | 2.76 | 3.73 | 2.25 | 2.91 | 32,544 | -0.435 | -15.76% |
| 6 Months | 2.71 | 3.73 | 2.25 | 2.89 | 38,088 | -0.385 | -14.21% |
| 1 Year | 3.70 | 4.75 | 1.9382 | 3.20 | 69,847 | -1.38 | -37.16% |
| 3 Years | 8.03 | 8.60 | 1.12 | 3.19 | 105,414 | -5.71 | -71.05% |
| 5 Years | 3.68 | 10.88 | 1.12 | 4.38 | 101,003 | -1.36 | -36.82% |
DiaMedica Therapeutics Description
| DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. |
